Duration Guidelines Based on Clinical Evidence Current medical guidelines recommend continuing GLP-1 therapy indefinitely for patients with obesity or weight-related metabolic conditions, similar to how blood pressure or cholesterol medications are managed long-term
GV has received lecture and/or consulting fees from Ipsen, Pfizer, Novo Nordisk, Recordati, Takeda and HRA Pharma, and is Research Investigator in studies sponsored by Novartis, Recordati, Corcept, Chiasma and Takeda
The clinic also offers bio-identical hormone replacement therapy for those seeking additional health support
42 For pharmacy technicians, The Forage created a simulator that delivers a free, fast-paced retail pharmacy re-creation that even provides a certificate after completion
What can make diarrhea worse while taking GLP-1 drugs
Our clinical manuscript also details the safety of the individual antibodies administered alone and in combination